We are live on
!
Find out more
OI
Oakbrook Investments Portfolio holdings
AUM
$39.2M
1-Year Est. Return
3.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.78%
1 Year Est. Return
-3.66%
3 Year Est. Return
+26.09%
5 Year Est. Return
+53.43%
10 Year Est. Return
–
AUM
$1.8B
AUM Growth
+$220M
(+14%)
Cap. Flow
+$92.2M
Cap. Flow
% of AUM
5.11%
Top 10 Holdings %
Top 10 Hldgs %
23.35%
Holding
698
New
144
Increased
374
Reduced
112
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Colgate-Palmolive
CL
|
+$23M |
| 2 |
Mondelez International
MDLZ
|
+$11.8M |
| 3 |
General Mills
GIS
|
+$11.6M |
| 4 |
Johnson & Johnson
JNJ
|
+$8.36M |
| 5 |
Salesforce
CRM
|
+$5.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$23.4M |
| 2 |
Visa
V
|
+$13.3M |
| 3 |
Autodesk
ADSK
|
+$10.2M |
| 4 |
PepsiCo
PEP
|
+$9.62M |
| 5 |
Oracle
ORCL
|
+$6.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.28% |
| 2 | Healthcare | 15.36% |
| 3 | Financials | 15.12% |
| 4 | Consumer Discretionary | 11.34% |
| 5 | Industrials | 11.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Curtiss-Wright
CW
$25.5B
| $378K | 0.02% |
2,750
-1,350
| -33% | -$177K |
|
|
SEE
502
DELISTED
Sealed Air
SEE
| $376K | 0.02% |
+9,370
| New | +$388K |
|
|
AIV
503
Aimco
AIV
$383M
| $374K | 0.02% |
63,665
+18,016
| +39% | +$104K |
|
|
VVC
504
DELISTED
Vectren Corporation
VVC
| $371K | 0.02% |
5,190
+1,300
| +33% | +$92.8K |
|
505
Watsco Inc
WSO
$13.6B
| $370K | 0.02% |
+2,075
| New | +$367K |
|
|
HDS
506
DELISTED
HD Supply Holdings, Inc.
HDS
| $360K | 0.02% |
+8,410
| New | +$368K |
|
|
GAP
507
The Gap Inc
GAP
$7.37B
| $359K | 0.02% |
+12,440
| New | +$373K |
|
|
WBC
508
DELISTED
WABCO HOLDINGS INC.
WBC
| $358K | 0.02% |
+3,035
| New | +$367K |
|
509
Allison Transmission
ALSN
$9.82B
| $356K | 0.02% |
+6,850
| New | +$321K |
|
|
ACC
510
DELISTED
American Campus Communities, Inc.
ACC
| $354K | 0.02% |
8,609
+2,200
| +34% | +$92K |
|
511
Diamondback Energy
FANG
$52.7B
| $351K | 0.02% |
+2,600
| New | +$332K |
|
|
BERY
512
DELISTED
Berry Global Group, Inc.
BERY
| $351K | 0.02% |
+7,895
| New | +$347K |
|
513
First Horizon
FHN
$12.1B
| $350K | 0.02% |
20,300
-10,200
| -33% | -$184K |
|
|
DNB
514
DELISTED
Dun & Bradstreet
DNB
| $349K | 0.02% |
2,450
-1,250
| -34% | -$170K |
|
515
Woodward
WWD
$21.4B
| $348K | 0.02% |
4,300
+100
| +2% | +$8.03K |
|
|
SNV
516
DELISTED
Synovus
SNV
| $346K | 0.02% |
7,557
-3,600
| -32% | -$181K |
|
517
Lazard
LAZ
$4.31B
| $345K | 0.02% |
+7,177
| New | +$357K |
|
518
Ciena
CIEN
$58.4B
| $344K | 0.02% |
11,000
| – | – |
|
|
MPT
519
Medical Properties Trust
MPT
$2.81B
| $340K | 0.02% |
22,800
+5,800
| +34% | +$84.6K |
|
520
TripAdvisor
TRIP
$1.26B
| $340K | 0.02% |
6,650
+1,700
| +34% | +$92.9K |
|
521
Royal Gold
RGLD
$19.5B
| $339K | 0.02% |
4,400
+1,100
| +33% | +$90.5K |
|
522
Emcor
EME
$36B
| $338K | 0.02% |
4,500
| – | – |
|
523
SM Energy
SM
$6.87B
| $337K | 0.02% |
+10,700
| New | +$307K |
|
|
ATHN
524
DELISTED
Athenahealth, Inc.
ATHN
| $337K | 0.02% |
+2,525
| New | +$378K |
|
525
Littelfuse
LFUS
$11.6B
| $336K | 0.02% |
1,700
+400
| +31% | +$88K |
|
Similar funds
MF
AIM
QCMA
SC
BIM
GP
GAM
SCM
Oakbrook Investments's Q3 2018 Portfolio in Review
As of Q3 2018, Oakbrook Investments held 698 positions worth $1.8B, up 14% from $1.58B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Oakbrook Investments deployed $92.2M of net new capital in Q3 2018, opening 144 new positions and adding to 374 existing holdings. Its largest new stake was Colgate-Palmolive: 345,909 shares worth $23.2M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $23.4M trimmed.
- Oakbrook Investments's largest Q3 2018 buy was Colgate-Palmolive: 345,909 shares worth $23.2M.
- Oakbrook Investments added most to Mondelez International in Q3 2018, an estimated $11.8M increase.
- Oakbrook Investments's biggest Q3 2018 reduction was Gilead Sciences, cutting an estimated $23.4M.
- Oakbrook Investments fully exited CSX Corp in Q3 2018, selling an estimated $3.83M.
- Oakbrook Investments's ten largest holdings make up 23% of its $1.8B portfolio in Q3 2018.
- Oakbrook Investments opened 144 new positions and closed 60 in Q3 2018.
- Oakbrook Investments's portfolio value rose 14% quarter-over-quarter to $1.8B.
Based on Oakbrook Investments's 13F filing for Q3 2018, filed 18 Oct 2018.